Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 4, 2014, Pages 449-462

  Oshansky, Christine M ^a   Gartland, Andrew J ^b   Wong, Sook San ^a   Jeevan, Trushar ^a   Wang, David ^a   Roddam, Philippa L ^c,d,e   Caniza, Miguela A ^a,c   Hertz, Tomer ^b   DeVincenzo, John P ^c,d,e,f   Webby, Richard J ^a   Thomas, Paul G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Department of Pediatrics ^*  (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^e LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^f LE BONHEUR CHILDREN S HOSPITAL   (United States)

Author keywords

Cytokine; Human; Innate immune response; Monocyte; Natural influenza virus infection

Indexed keywords

ADOLESCENT; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CHEMOTAXIS, LEUKOCYTE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HOSPITALIZATION; HUMANS; IMMUNITY, INNATE; INFANT; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; MALE; MONOCYTES; NASAL LAVAGE FLUID; PROGNOSIS; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; VIRAL LOAD; YOUNG ADULT;

EID: 84894231691     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201309-1616OC     Document Type: Article

References (35)

1. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011;208:181-193.
2. Liu W, de Vlas SJ, Tang F, Ma MJ, Wei MT, Liu LJ, Li ZD, Zhang L, Xin ZT, Tong YG, et al. Clinical and immunological characteristics of patients with 2009 pandemic influenza A (H1N1) virus infection after vaccination. Clin Infect Dis 2010;51:1028-1032.
3. Baluch A, Humar A, Egli A, Gubbay J, Lisboa L, Wilson L, Kumar D. Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients. PLoS ONE 2011;6: e28627.
4. Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis 1986;154:121-127.
5. Richards KA, Topham D, Chaves FA, Sant AJ. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J Immunol 2010;185:4998-5002.
6. Sato M, Hosoya M, Wright PF. Differences in serum cytokine levels between influenza virus A and B infections in children. Cytokine 2009; 47:65-68.
7. Oshansky CM, Thomas PG. The human side of influenza. J Leukoc Biol 2012;92:83-96.
8. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of selfpreservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007;85:85-92.
9. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1207.
10. Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, Ngai KL, Lui GC, Wong BC, Lee SK, et al. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS ONE 2011;6:e26050.
11. Paquette SG, Banner D, Zhao Z, Fang Y, Huang SS, Leomicronn AJ, Ng DC, Almansa R, Martin-Loeches I, Ramirez P, et al. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS ONE 2012;7:e38214.
12. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004;363:617-619.
13. Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, et al. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 2010;14:R203.
14. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, et al.; GenISIS Investigators; MOSAIC Investigators. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012;484:519-523.
15. Zhao Y, Zhang YH, Denney L, Young D, Powell TJ, Peng YC, Li N, Yan HP, Wang DY, Shu YL, et al. High levels of virus-specific CD41 T cells predict severe pandemic influenza A virus infection. Am J Respir Crit Care Med 2012;186:1292-1297.
16. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, et al. Preexisting influenza-specific CD41 T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012;18: 274-280.
17. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, et al.; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;59: 1-62.
18. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010;33:375-386.
19. Pickering LK, editor. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
20. Iskander M, Booy R, Lambert S. The burden of influenza in children. Curr Opin Infect Dis 2007;20:259-263.
21. Zinkernagel RM. Immunological memory not equal protective immunity. Cell Mol Life Sci 2012;69:1635-1640.
22. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, Suzuki H, Nishimura H, Mitamura K, Sugaya N, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004;431:703-707.
23. Lee N, Chan PK, Wong CK, Wong KT, Choi KW, Joynt GM, Lam P, Chan MC, Wong BC, Lui GC, et al. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir Ther 2011;16:237-247.
24. Wen Y, Deng BC, Zhou Y, Wang Y, Cui W, Wang W, Liu P. Immunological features in patients with pneumonitis due to influenza A H1N1 infection. J Investig Allergol Clin Immunol 2011; 21:44-50.
25. Welliver TP, Reed JL, Welliver RC , Sr. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr Infect Dis J 2008;27(Suppl. 10):S92-S96.
26. Heltzer ML, Coffin SE, Maurer K, Bagashev A, Zhang Z, Orange JS, Sullivan KE. Immune dysregulation in severe influenza. J Leukoc Biol 2009;85:1036-1043.
27. Kim YH, Kim JE, Hyun MC. Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection. Pediatr Pulmonol 2011;46:1233-1239.
28. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Förster I, Farlik M, Decker T, Du Pasquier RA, Romero P, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011;34:213-223.
29. Sun J, Madan R, Karp CL, Braciale TJ. Effector T cells control lung inflammation during acute influenza virus infection by producing IL- 10. Nat Med 2009;15:277-284.
30. Vareille M, Kieninger E, Edwards MR, Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev 2011;24:210-229.
31. Aldridge JR Jr, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, Brown SA, Doherty PC, Webster RG, Thomas PG. TNF/ iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci USA 2009;106: 5306-5311.
32. Morales-Garćia G, Falfán-Valencia R, Garćia- Raḿirez RA, Camarena A, Ramirez-Venegas A, Castillejos-López M, Pérez-Rodŕiguez M, González-Bonilla C, Grajales- Muñ́iz C, Borja-Aburto V, et al. Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study. BMC Infect Dis 2012;12:299.
33. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH, Yan HP, Wu H, Liu JH, Liu N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-c is associated with severe influenza in Chinese individuals. Nature Communications 2013;4:1418.
34. Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database Syst Rev 2012;4:CD002744.
35. Abeles RD, McPhail MJ, Sowter D, Antoniades CG, Vergis N, Vijay GK, Xystrakis E, Khamri W, Shawcross DL, Ma Y, et al. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(HI) /CD16(neg) monocytes: expansion of CD14(HI) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure. Cytometry Part A 2012;81:823-834.